Page last updated: 2024-08-24

formamidine and Alveolar Bone Atrophy

formamidine has been researched along with Alveolar Bone Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hajishengallis, G; Maekawa, T	1

Other Studies

1 other study(ies) available for formamidine and Alveolar Bone Atrophy

Article	Year
Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss. Journal of periodontal research, 2014, Volume: 49, Issue:6 Topics: Administration, Topical; Alveolar Bone Loss; Amidines; Animals; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Load; Cell Line; Cytokines; Escherichia coli; Humans; Hydrolases; Interleukin-17; Interleukin-1beta; Interleukin-6; Levilactobacillus brevis; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Periodontitis; Placebos; Porphyromonas gingivalis; Probiotics; Tumor Necrosis Factor-alpha	2014

Article

Year

Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.

Journal of periodontal research, 2014, Volume: 49, Issue:6

Topics: Administration, Topical; Alveolar Bone Loss; Amidines; Animals; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Load; Cell Line; Cytokines; Escherichia coli; Humans; Hydrolases; Interleukin-17; Interleukin-1beta; Interleukin-6; Levilactobacillus brevis; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Periodontitis; Placebos; Porphyromonas gingivalis; Probiotics; Tumor Necrosis Factor-alpha

2014